cognitive cybersecurity intelligence

News and Analysis

What to Know About Newly Approved Alzheimer’s Drug

Jan. 6, 2023 — The highly anticipated Alzheimer’s drug lecanemab was granted accelerated approval status this afternoon by the FDA, offering hope where there has been little for patients and their families affected by the devastating disease.More than 6 million people in the U.S. live with…

Source: www.webmd.com – Read more

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

New ResokerRAT Uses Telegram Bot API to Control Infected Windows Systems

A new Remote Access Trojan (RAT) called ResokerRAT has been found targeting Windows systems by abusing Telegram’s widely used Bot API to receive commands and

BKA Identifies REvil Leaders Behind 130 German Ransomware Attacks

Germany’s Federal Criminal Police Office (aka BKA or the Bundeskriminalamt) has unmasked the real identity of the main threat actors associated with the now-defunct REvil

Threat Actors Weaponize Fake Microsoft Teams Domains to Target Users

Threat actors associated with North Korea are deploying fake Microsoft Teams domains to conduct social engineering attacks and distribute malware. The threat group, identified as

How Agentic AI Systems block Malware development and Cyber Threat campaigns – Cybersecurity Insiders

How Agentic AI Systems block Malware development and Cyber Threat campaigns Cybersecurity Insiders

News and Analysis

What to Know About Newly Approved Alzheimer’s Drug

Subscribe to newsletter

More Posts

New ResokerRAT Uses Telegram Bot API to Control Infected Windows Systems

BKA Identifies REvil Leaders Behind 130 German Ransomware Attacks

Threat Actors Weaponize Fake Microsoft Teams Domains to Target Users

How Agentic AI Systems block Malware development and Cyber Threat campaigns – Cybersecurity Insiders

Products

Solutions

Healthcare cybersecurity

Healthcare Threat Intelligence

Use Cases

News and Analysis

Insights

Company